Henry Schein Inc. closed 9.71% below its 52-week high of $82.49, which the company reached on February 5th.

Melville, New York-based Henry Schein, Inc. (HSIC) provides healthcare products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. With a market cap ...

Henry Schein currently trades 11.8% below its 52-week high of $82.49 recorded on Feb. 5. HSIC's stock has gained 4.9% over the past three months, outpacing the broader Dow Jones Industrial Average ...

According to Benzinga Pro, Henry Schein's peer group average for short interest as a percentage of float is 4.30%, which means the company has more short interest than most of its peers. Did you know ...

Henry Schein reaffirmed its adjusted annual profit forecast of $4.80 to $4.94 per share, compared with analysts' average estimate of $4.86 per share, according to data compiled by LSEG.

Nine analysts surveyed by Zacks expected $3.23 billion. Henry Schein expects full-year earnings in the range of $4.80 to $4.94 per share. _____ ...

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories.

Looking ahead, Henry Schein projects total sales growth of 2-4% for 2025, with non-GAAP diluted EPS expected to range between $4.80 and $4.94.

KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic ...

Henry Schein has finally disclosed a data breach following at least two back-to-back cyberattacks in 2023 by the BlackCat Ransomware gang, revealing that over 160,000 people had their personal ...